Search

Search Constraints

You searched for: Author/Creator Ruschitzka, Frank

Search Results

21. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry. (1st April 2020)

22. Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (7th December 2021)

23. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society. (6th August 2020)

24. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. (10th October 2017)

25. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology. (15th May 2016)

26. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry. (16th May 2019)

27. Cardiac implantable electronic devices with a defibrillator component and all‐cause mortality in left ventricular assist device carriers: results from the PCHF‐VAD registry. (13th August 2019)

28. Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial. Issue 6 (2nd March 2022)

29. Cardiovascular magnetic resonance T2* mapping for structural alterations in hypertrophic cardiomyopathy. (2019)

30. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy. Issue 1 (15th March 2020)